<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The prevalence of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> is increasing worldwide with <z:mp ids='MP_0001261'>obese</z:mp> diabetic patients constituting the majority of this population </plain></SENT>
<SENT sid="1" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with increased morbidity and mortality after <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Previous experimental studies of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>-reperfusion tolerance in <z:mp ids='MP_0002055'>diabetes</z:mp> have only been performed in animal models of type 1 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, yielding conflicting data </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of the present study was to characterise and compare the tolerance to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> and effects of ischaemic preconditioning (<z:chebi fb="76" ids="53004">IPC</z:chebi>) in hearts from <z:mp ids='MP_0001261'>obese</z:mp> <z:chebi fb="3" ids="16646">Zucker</z:chebi> diabetic fatty (ZDF) and lean Goto-Kakizaki (GK) type 2 diabetic rats, using non-<z:mp ids='MP_0001261'>obese</z:mp> <z:chebi fb="3" ids="16646">Zucker</z:chebi> and Wistar rats as respective controls </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: The two rat strains were divided into 8 groups </plain></SENT>
<SENT sid="5" pm="."><plain>The ZDF study (n=47) consisted of: Control -<z:chebi fb="76" ids="53004">IPC</z:chebi>, Control +<z:chebi fb="76" ids="53004">IPC</z:chebi>, ZDF -<z:chebi fb="76" ids="53004">IPC</z:chebi> and ZDF +<z:chebi fb="76" ids="53004">IPC</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>The GK study (n=38) consisted of: Control -<z:chebi fb="76" ids="53004">IPC</z:chebi>, Control +<z:chebi fb="76" ids="53004">IPC</z:chebi>, GK -<z:chebi fb="76" ids="53004">IPC</z:chebi> and GK +<z:chebi fb="76" ids="53004">IPC</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Hearts, which were studied in a Langendorff preparation perfused with Krebs-Henseleit buffer, were subjected or not to <z:chebi fb="76" ids="53004">IPC</z:chebi> (+<z:chebi fb="76" ids="53004">IPC</z:chebi>, -<z:chebi fb="76" ids="53004">IPC</z:chebi>) before 50 minutes of regional <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> and 120 minutes reperfusion </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Ischaemic reperfusion injury was smaller in <z:mp ids='MP_0001261'>obese</z:mp> (p&lt;0.05) and lean (p&lt;0.05) type 2 diabetic animals than in their respective control animals </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="76" ids="53004">IPC</z:chebi> reduced ischaemic reperfusion injury during reperfusion in non-diabetic control rats (p&lt;0.01), but failed to protect hearts from both diabetic animal models </plain></SENT>
<SENT sid="10" pm="."><plain>Post-ischaemic haemodynamic recovery was impaired in the ZDF rats compared to both control and GK rats (p&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: Ischaemic preconditioning does not protect hearts from <z:mp ids='MP_0001261'>obese</z:mp> or lean type 2 diabetic animals </plain></SENT>
<SENT sid="12" pm="."><plain>However, the susceptibility of the type 2 diabetic myocardium to ischaemic damage is lower than in non-diabetic hearts </plain></SENT>
<SENT sid="13" pm="."><plain>The method described here could be used as a tool to study the pathogenesis of increased <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> and mortality in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>